Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients.

Guido GembilloRossella SiligatoValeria CernaroErsilia SattaGiovanni ContiAntonino SalvoAdolfo RomeoVincenzo CalabreseGiovanna SpositoGuido FerlazzoDomenico Santoro

Published in: International urology and nephrology (2021)

MHR may be a reliable biomarker due to the connection between HDL and monocytes. Our study suggests that MHR is linked with the use of multiple anti-hypertensive therapy and resistant hypertension in CKD patients, and can be a useful ratio to implement appropriate treatment strategies.

Keyphrases

end stage renal disease
chronic kidney disease
blood pressure
newly diagnosed
prognostic factors
dendritic cells
immune response
peripheral blood
mesenchymal stem cells
bone marrow
endothelial cells
cell therapy